Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
Radiat Oncol. 2020 May 24;15(1):121. doi: 10.1186/s13014-020-01572-w.
Patients with left-sided breast cancer frequently receive deep inspiration breath-hold (DIBH) radiotherapy to reduce the risk of cardiac side effects. The aim of the present study was to analyze intra-breath-hold stability and inter-fraction breath-hold reproducibility in clinical practice.
Overall, we analyzed 103 patients receiving left-sided breast cancer radiotherapy using a surface-guided DIBH technique. During each treatment session the vertical motion of the patient was continuously measured by a surface guided radiation therapy (SGRT) system and automated gating control (beam on/off) was performed using an audio-visual patient feedback system. Dose delivery was automatically triggered when the tracking point was within a predefined gating window. Intra-breath-hold stability and inter-fraction reproducibility across all fractions of the entire treatment course were analyzed per patient.
In the present series, 6013 breath-holds during beam-on time were analyzed. The mean amplitude of the gating window from the baseline breathing curve (maximum expiration during free breathing) was 15.8 mm (95%-confidence interval: [8.5-30.6] mm) and had a width of 3.5 mm (95%-CI: [2-4.3] mm). As a measure of intra-breath-hold stability, the median standard deviation of the breath-hold level during DIBH was 0.3 mm (95%-CI: [0.1-0.9] mm). Similarly, the median absolute intra-breath-hold linear amplitude deviation was 0.4 mm (95%-CI: [0.01-2.1] mm). Reproducibility testing showed good inter-fractional reliability, as the maximum difference in the breathing amplitudes in all patients and all fractions were 1.3 mm on average (95%-CI: [0.5-2.6] mm).
The clinical integration of an optical surface scanner enables a stable and reliable DIBH treatment delivery during SGRT for left-sided breast cancer in clinical routine.
左侧乳腺癌患者常接受深吸气屏气(DIBH)放疗,以降低心脏副作用的风险。本研究旨在分析临床实践中屏气过程中的稳定性和分次间呼吸可重复性。
共分析了 103 例接受左侧乳腺癌放疗的患者,采用表面引导 DIBH 技术。在每次治疗过程中,患者的垂直运动通过表面引导放疗(SGRT)系统连续测量,并使用视听患者反馈系统进行自动门控控制(开/关)。当跟踪点位于预设的门控窗口内时,自动触发剂量输送。对整个治疗过程中所有分次的每个患者的屏气过程中的稳定性和分次间呼吸可重复性进行分析。
在本系列中,分析了 6013 个屏气期间的束流开启时间。从基线呼吸曲线(自由呼吸时最大呼气)到门控窗口的平均振幅为 15.8mm(95%置信区间:[8.5-30.6]mm),宽度为 3.5mm(95%置信区间:[2-4.3]mm)。作为屏气过程中的稳定性指标,DIBH 时屏气水平的中位数标准差为 0.3mm(95%置信区间:[0.1-0.9]mm)。同样,中位数绝对屏气线性幅度偏差为 0.4mm(95%置信区间:[0.01-2.1]mm)。重复性测试显示出良好的分次间可靠性,因为所有患者和所有分次的呼吸幅度最大差异平均为 1.3mm(95%置信区间:[0.5-2.6]mm)。
光学表面扫描仪的临床整合使左侧乳腺癌 SGRT 治疗在临床常规中能够稳定、可靠地进行 DIBH 治疗。